Floatz logo

SUFENTANYL

Liver Cirrhosis(Who Will Undergo Planed Liver Transplantation)

Yonsei UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Liver Cirrhosis(Who Will Undergo Planed Liver Transplantation) cohort.

Asset / SponsorPhaseRating
Desflurane
Yonsei University
N/AD

Same molecule, other indications

SUFENTANYL is also rated in:

chronic pain syndromeDormant
BB
Indicative ·
69 / 100
View asset →
AnalgesicsDormant
BB
Indicative ·
68 / 100
View asset →
Post Operative PainDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →